Original Article
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Original Article
- Original Article
- Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
- George KK Lau, Nancy Leung
- Clin Mol Hepatol. 2010;16(3):315-320. Published online September 30, 2010
-
View: 7036 Download: 40 Crossref: 10
- Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
- Oh Sang Kwon, Young Kul Jung, Yun Soo Kim, Sang Gyune Kim, Young Seok Kim, Jung Il Lee, Jin Woo Lee, Young Soo Kim, Byung Chul Chun, Ju Hyun Kim
- Clin Mol Hepatol. 2010;16(3):308-314. Published online September 30, 2010
-
View: 6776 Download: 60 Crossref: 8
- Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis
- Mi Yeon Chung, Dae Won Jun, Su Ah Sung
- Clin Mol Hepatol. 2010;16(3):301-307. Published online September 30, 2010
-
View: 9782 Download: 76 Crossref: 19
- Factors influencing the severity of acute viral hepatitis A
- Joo Il Kim, Yun Soo Kim, Young Kul Jung, Oh Sang Kwon, Yeon Suk Kim, Yang Suh Ku, Duck Joo Choi, Ju Hyun Kim
- Clin Mol Hepatol. 2010;16(3):295-300. Published online September 30, 2010
-
View: 7507 Download: 84 Crossref: 16
- Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
- Sang Hyub Lee, Sook-Hyang Jeong, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Nayoung Kim, Dong Ho Lee
- Clin Mol Hepatol. 2010;16(3):288-294. Published online September 30, 2010
-
View: 6989 Download: 47 Crossref: 15
- Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
- Sung Hoon Choi, Hye Won Shin, Jun Yong Park, Ji Young Yoo, Do Young Kim, Weon Sang Ro, Chae-Ok Yun, Kwang-Hyub Han
- Clin Mol Hepatol. 2010;16(3):280-287. Published online September 30, 2010
-
View: 8812 Download: 63 Crossref: 11
- Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
- Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
- Received December 21, 2023 Accepted March 8, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0553 [Epub ahead of print]
-
View: 1112 Download: 192
- Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
- Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
- Received January 17, 2024 Accepted March 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0042 [Epub ahead of print]
-
View: 1191 Download: 154
- Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients
- Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
- Received December 16, 2023 Accepted March 25, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0535 [Epub ahead of print]
-
View: 760 Download: 61
- Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
- Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin
- Received December 27, 2023 Accepted April 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0563 [Epub ahead of print]
-
View: 719 Download: 38
- Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
- Received February 9, 2024 Accepted April 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0103 [Epub ahead of print]
-
View: 877 Download: 78
- Ischemia-free liver transplantation improves the prognosis of recipients using Functioned Marginal Liver grafts
- Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen
- Received February 22, 2024 Accepted April 11, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0139 [Accepted]
-
View: 684 Download: 72
- Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
- Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
- Received January 18, 2024 Accepted April 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0047 [Accepted]
-
View: 1067 Download: 176
- Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
- Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone Strasser, Jacob George
- Received February 15, 2024 Accepted April 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0109 [Accepted]
-
View: 1066 Download: 130 Crossref: 1
- Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
- Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Wan-Long, Ming-Jong Bair, Ming-Lung Yu
- Received January 16, 2024 Accepted April 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0038 [Accepted]
-
View: 1015 Download: 93
- Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and the risk of hepatocellular carcinoma: a nationwide cohort study
- Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park
- Received February 4, 2024 Accepted May 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0145 [Accepted]
-
View: 553 Download: 66
- Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study
- Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
- Received January 20, 2024 Accepted May 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0055 [Accepted]
-
View: 417 Download: 59
- Macrophage ATG16L1 expression suppresses MASH progression by promoting lipophagy
- Qi Wang, Qingfa Bu, Zibo Xu, Yuan Liang, Jinren Zhou, Yufeng Pan, Haoming Zhou, Ling Lu
- Received February 13, 2024 Accepted May 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0107 [Accepted]
-
View: 727 Download: 113
- Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
- Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
- Received January 22, 2024 Accepted May 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0060 [Accepted]
-
View: 835 Download: 111
- Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC
- Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
- Received January 20, 2024 Accepted May 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0058 [Accepted]
-
View: 415 Download: 52
- Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
- Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong eun Lee, Dae Won Jun, Yuri Cho
- Received September 27, 2023 Accepted June 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0384 [Accepted]
-
View: 461 Download: 34
- Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023
- Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Received April 29, 2024 Accepted June 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0318 [Accepted]
-
View: 171 Download: 7
- UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
- Renyu Zhang, Can Li, Shuai Zhang, Lingmin Kong, Zekun Liu, Yixiao Guo, Ying Sun, Cong Zhang, Yule Yong, Jianjun Lv, Meng Lu, Man Liu, Dong Wu, Tianjiao Zhang, Haijiao Yang, Ding Wei, Zhinan Chen, Huijie Bian
- Received April 7, 2024 Accepted June 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0236 [Accepted]
-
View: 144 Download: 27
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
